Nisa Investment Advisors LLC raised its position in SIGA Technologies, Inc. (NASDAQ:SIGA – Get Rating) by 253.7% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 15,413 shares of the company's stock after buying an additional 11,055 shares during the quarter. Nisa Investment Advisors LLC's holdings in SIGA Technologies were worth $178,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Campbell & CO Investment Adviser LLC grew its holdings in SIGA Technologies by 8.8% in the 1st quarter. Campbell & CO Investment Adviser LLC now owns 23,399 shares of the company's stock valued at $166,000 after buying an additional 1,899 shares in the last quarter. Timelo Investment Management Inc. acquired a new stake in shares of SIGA Technologies during the 2nd quarter worth $579,000. Exchange Traded Concepts LLC acquired a new stake in shares of SIGA Technologies during the 1st quarter worth $512,000. Kempen Capital Management N.V. grew its holdings in shares of SIGA Technologies by 19.5% during the 1st quarter. Kempen Capital Management N.V. now owns 1,376,982 shares of the company's stock worth $9,763,000 after purchasing an additional 224,423 shares in the last quarter. Finally, Aaron Wealth Advisors LLC acquired a new stake in shares of SIGA Technologies during the 1st quarter worth $548,000. 42.55% of the stock is owned by institutional investors and hedge funds.
Get SIGA Technologies alerts:SIGA Technologies Stock Performance
SIGA opened at $9.21 on Monday. The firm has a market cap of $672.55 million, a P/E ratio of 6.35 and a beta of 0.73. SIGA Technologies, Inc. has a 52-week low of $5.84 and a 52-week high of $26.99. The business's fifty day moving average is $10.90 and its 200-day moving average is $12.51.
SIGA Technologies (NASDAQ:SIGA – Get Rating) last released its earnings results on Thursday, August 4th. The company reported $0.03 earnings per share (EPS) for the quarter. The company had revenue of $16.67 million for the quarter. SIGA Technologies had a return on equity of 67.19% and a net margin of 50.24%.SIGA Technologies Profile
(Get Rating)
SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats.
Featured Articles
- Get a free copy of the StockNews.com research report on SIGA Technologies (SIGA)
- Edwards Life Sciences Stock Disaster Could Be Your Bounty
- It Not All Bad News for Advanced Micro Devices Stock
- After Doubling, First Solar May Keep Shining
- Barrick Gold is a Hold as Long as Gold Prices Stay Stagnant
- MarketBeat: Week in Review 10/31-11/4
Receive News & Ratings for SIGA Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SIGA Technologies and related companies with MarketBeat.com's FREE daily email newsletter.